Hemab Therapeutics Holdings Inc (COAG) saw its stock price soar 50.00% intraday on Friday, marking a dramatic debut on the public market.
The surge follows the company's announcement that it priced its initial public offering of 16.8 million shares at $18 per share, raising $301.5 million. Shares began trading on the Nasdaq Global Select Market on Friday under the ticker "COAG," with the first-day rally reflecting strong investor demand for the newly listed stock.